IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q3 2025 Holdings

Filed 2025-11-12 | 14 holdings | $456.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$316.3M6,089,61169.3%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$65.7M615,35214.4%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$20.3M1,316,8064.4%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$11.0M2,960,6592.4%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$10.9M1,472,3312.4%
Bicara Therapeutics Inc. (Bcax)(BCAX)COM055477103$9.0M568,9192.0%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$6.9M1,198,4181.5%
BridgeBio Oncology Therapeutics (Bbot)(BBOT)COM NEW107924102$6.5M564,6251.4%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$4.1M2,048,7570.9%
Scholar Rock Holding Corporation (Srrk)(SRRK)COM80706P103$2.9M77,0310.6%
CalciMedica, Inc. (Calc)(CALC)COM NEW38942Q202$1.6M521,1140.4%
Aclaris Therapeutics Inc (Acrs)(ACRS)COM00461U105$825.5K434,4550.2%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM NEW57055L206$290.4K325,3700.1%
OnKure Therapeutics, Inc. (Okur)(OKUR)COM CL A68277Q105$243.7K88,6070.1%